Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Cresco Labs ( (TSE:CL) ) just unveiled an update.
Cresco Labs announced it will release its second-quarter 2025 financial results on August 7, 2025. The company will host a conference call and webcast to discuss these results and provide key business highlights. This announcement is significant as it provides stakeholders with insights into the company’s financial health and strategic direction, potentially impacting its market positioning and investor relations.
The most recent analyst rating on (TSE:CL) stock is a Buy with a C$4.00 price target. To see the full list of analyst forecasts on Cresco Labs stock, see the TSE:CL Stock Forecast page.
Spark’s Take on TSE:CL Stock
According to Spark, TipRanks’ AI Analyst, TSE:CL is a Neutral.
Cresco Labs’ stock score is driven by improving financial performance and strategic growth initiatives, counterbalanced by negative valuation metrics and mixed technical signals. Revenue challenges and high leverage are significant risks impacting the score.
To see Spark’s full report on TSE:CL stock, click here.
More about Cresco Labs
Cresco Labs Inc. is a leading company in the cannabis industry, focusing on branded cannabis products and operating Sunnyside dispensaries. The company aims to professionalize the cannabis sector through a consumer packaged goods approach, offering a diverse portfolio of national brands such as Cresco, High Supply, FloraCal, and others. Cresco Labs is committed to community engagement, economic opportunity, and legislative initiatives to foster a responsible and robust cannabis industry.
Average Trading Volume: 355,649
Technical Sentiment Signal: Sell
Current Market Cap: C$325.7M
See more data about CL stock on TipRanks’ Stock Analysis page.